Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7403 p646
3 June 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Membership/registration do not need to be linked

Link between Society membership and registration is not necessary, says NPA

Link between Society membership and registration is not necessary, says NPA

Registration as a practising pharmacist and membership of the Royal Pharmaceutical Society do not need to be linked, members of the National Pharmacy Association's board have argued.

Debating the association’s draft response to the Department of Health’s consultation on the planned Section 60 Order that will reform the regulation of pharmacy, board members said at their monthly meeting that registration as a practising pharmacist is all that is needed to ensure a safe and quality service and that Society membership adds nothing to this. However, they also wanted there to be both practising and non-practising registers and a wider definition of a practising pharmacist than the draft Order proposed. Board members were concerned that the proposed definition failed to include pharmacists in management, administration, marketing and public relations or journalism.

Compulsory registration of pharmacy technicians was not a proposal that found favour during the discussion. But board members took the view that both practising pharmacists and technicians should have to be able to show that their knowledge is up to date by keeping continuing professional development portfolios.

There was also concern over the proposal that the attitude and behaviour of potential pharmacists should be included in the preregistration process. This would entail a subjective judgement and applicants with any extreme views — professional or otherwise — could be excluded. Board members wanted there to be an objective scorecard or some other approach that excluded bias or prejudice before they could support this proposal.

The planned fitness-to-practise procedures caused further concern, with board members expressing the view that they gave the Society too much power. They were also worried about the cost of the new regulatory regime to Society members.

Back to Top


©The Pharmaceutical Journal